Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures

Neurobiology of Disease

Volumn 58, Issue , 2013, Pages 102-114

  Iori, Valentina ^a   Maroso, Mattia ^a   Rizzi, Massimo ^a   Iyer, Anand M ^c,d   Vertemara, Roberta ^a   Carli, Mirjana ^a   Agresti, Alessandra ^b   Antonelli, Antonella ^b   Bianchi, Marco E ^b   Aronica, Eleonora ^c,d   Ravizza, Teresa ^a   Vezzani, Annamaria ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

Alarmin; Cell loss; Damage associated molecular pattern; DAMP; Glia; Inflammation; Neurogenesis; Seizures; Toll like receptor

Indexed keywords

ADVANCED GLYCATION END PRODUCT; DOUBLECORTIN; GLUTAMATE RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL LOSS; COGNITIVE DEFECT; CONTROLLED STUDY; EPILEPTIC STATE; GRANULE CELL; HIPPOCAMPAL CA1 REGION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MESIAL TEMPORAL LOBE EPILEPSY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY; UPREGULATION;

ALARMIN; CELL LOSS; DAMAGE ASSOCIATED MOLECULAR PATTERN; DAMP; GLIA; INFLAMMATION; NEUROGENESIS; SEIZURES; TOLL-LIKE RECEPTOR;

ANIMALS; CELL DEATH; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; EPILEPSY, TEMPORAL LOBE; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HMGB1 PROTEIN; HUMANS; KAINIC ACID; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; NEUROPEPTIDES; RECEPTORS, IMMUNOLOGIC; SEIZURES; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84879735457     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.03.006     Document Type: Article

References (82)

1. Andrassy M., Volz H.C., Igwe J.C., Funke B., Eichberger S.N., Kaya Z., et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008, 117:3216-3226.
2. Andres-Mach M., Fike J.R., Luszczki J.J. Neurogenesis in the epileptic brain: a brief overview from temporal lobe epilepsy. Pharmacol. Rep. 2011, 63:1316-1323.
3. Antonucci F., Di Garbo A., Novelli E., Manno I., Sartucci F., Bozzi Y., et al. Botulinum neurotoxin E (BoNT/E) reduces CA1 neuron loss and granule cell dispersion, with no effects on chronic seizures, in a mouse model of temporal lobe epilepsy. Exp. Neurol. 2008, 210:388-401.
4. Aronica E., Leenstra S., Jansen G.H., van Veelen C.W., Yankaya B., Troost D. Expression of brain-derived neurotrophic factor and tyrosine kinase B receptor proteins in glioneuronal tumors from patients with intractable epilepsy: colocalization with N-methyl-d-aspartic acid receptor. Acta Neuropathol. 2001, 101:383-392.
5. Aronica E., Ravizza T., Zurolo E., Vezzani A. Astrocyte immune response in epilepsy. Glia 2012, 10.1002/glia.22312.
6. Balosso S., Ravizza T., Perego C., Peschon J., Campbell I.L., De Simoni M.G., et al. Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann. Neurol. 2005, 57:804-812.
7. Balosso S., Maroso M., Sanchez-Alavez M., Ravizza T., Frasca A., Bartfai T., et al. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain 2008, 131:3256-3265.
8. Balosso S., Ravizza T., Pierucci M., Calcagno E., Invernizzi R.W., Di Giovanni G., et al. Molecular and functional interactions between TNF-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility. Neuroscience 2009, 161:293-300.
9. Bengzon J., Kokaia Z., Elmer E., Nanobashvili A., Kokaia M., Lindvall O. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:10432-10437.
10. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 2007, 81:1-5.
11. Bianchi M.E., Manfredi A.A. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol. Rev. 2007, 220:35-46.
12. Bouilleret V., Ridoux V., Depaulis A., Marescaux C., Nehlig A., Le Gal La Salle G. Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synapticreorganization similar to mesial temporal lobe epilepsy. Neuroscience 1999, 89:717-729.
13. Bressand K., Deransart C., Delotterie D., Bouyssieres C., Dumont C., Roche Y., et al. Effects of commonly-used antiepileptic drugs in the MTLE mouse: a model of mesial temporal lobe epilepsy to explore new treatments for drug-resistant epilepsies?. Epilepsia 2011, 52(Suppl. 6):256.
14. Brown J.P., Couillard-Despres S., Cooper-Kuhn C.M., Winkler J., Aigner L., Kuhn H.G. Transient expression of doublecortin during adult neurogenesis. J. Comp. Neurol. 2003, 467:1-10.
15. Chavakis T., Bierhaus A., Nawroth P.P. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect. 2004, 6:1219-1225.
16. Chavan S.S., Huerta P.T., Robbiati S., Valdes-Ferrer S.I., Ochani M., Dancho M., et al. HMGB1 mediates cognitive impairment in sepsis survivors. Mol. Med. 2012, 18:930-937.
17. Deane R., Singh I., Sagare A.P., Bell R.D., Ross N.T., LaRue B., et al. A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease. J. Clin. Invest. 2012, 122:1377-1392.
18. Ding Q., Keller J.N. Evaluation of rage isoforms, ligands, and signaling in the brain. Biochim. Biophys. Acta 2005, 1746:18-27.
19. Duveau V., Fritschy J.M. PSA-NCAM-dependent GDNF signaling limits neurodegeneration and epileptogenesis in temporal lobe epilepsy. Eur. J. Neurosci. 2011, 32:89-98.
20. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2008, Academic Press, San Diego.
21. Frasca A., Aalbers M., Frigerio F., Fiordaliso F., Salio M., Gobbi M., et al. Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity. Neurobiol. Dis. 2011, 43:507-515.
22. Friedman A., Kaufer D., Heinemann U. Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res. 2009, 85:142-149.
23. Gao T.L., Yuan X.T., Yang D., Dai H.L., Wang W.J., Peng X., et al. Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury. J. Trauma Acute Care Surg. 2012, 72:643-649.
24. Gray W.P., Sundstrom L.E. Kainic acid increases the proliferation of granule cell progenitors in the dentate gyrus of the adult rat. Brain Res. 1998, 790:52-59.
25. Griffin W.S., Yeralan O., Sheng J.G., Boop F.A., Mrak R.E., Rovnaghi C.R., et al. Overexpression of the neurotrophic cytokine S100 beta in human temporal lobe epilepsy. J. Neurochem. 1995, 65:228-233.
26. Hanke M.L., Kielian T. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin. Sci. (Lond.) 2011, 121:367-387.
27. Hattiangady B., Rao M.S., Shetty A.K. Chronic temporal lobe epilepsy is associated with severely declined dentate neurogenesis in the adult hippocampus. Neurobiol. Dis. 2004, 17:473-490.
28. Heinrich C., Nitta N., Flubacher A., Muller M., Fahrner A., Kirsch M., et al. Reelin deficiency and displacement of mature neurons, but not neurogenesis, underlie the formation of granule cell dispersion in the epileptic hippocampus. J. Neurosci. 2006, 26:4701-4713.
29. Huttunen H.J., Kuja-Panula J., Sorci G., Agneletti A.L., Donato R., Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 2000, 275:40096-40105.
30. Jaulmes A., Thierry S., Janvier B., Raymondjean M., Marechal V. Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1beta. FASEB J. 2006, 20:1727-1729.
31. Jin Q., Chen H., Luo A., Ding F., Liu Z. S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE). PLoS One 2011, 6:e19375.
32. Keene C.D., Chang R., Stephen C., Nivison M., Nutt S.E., Look A., et al. Protection of hippocampal neurogenesis from toll-like receptor 4-dependent innate immune activation by ablation of prostaglandin E2 receptor subtype EP1 or EP2. Am. J. Pathol. 2009, 174:2300-2309.
33. Kook S.Y., Hong H.S., Moon M., Ha C.M., Chang S., Mook-Jung I. Abeta(1-42)-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca2+-calcineurin signaling. J. Neurosci. 2012, 32:8845-8854.
34. Kralic J.E., Ledergerber D.A., Fritschy J.M. Disruption of the neurogenic potential of the dentate gyrus in a mouse model of temporal lobe epilepsy with focal seizures. Eur. J. Neurosci. 2005, 22:1916-1927.
35. Kuruba R., Hattiangady B., Shetty A.K. Hippocampal neurogenesis and neural stem cells in temporal lobe epilepsy. Epilepsy Behav. 2009, 14(Suppl. 1):65-73.
36. Ledergerber D., Fritschy J.M., Kralic J.E. Impairment of dentate gyrus neuronal progenitor cell differentiation in a mouse model of temporal lobe epilepsy. Exp. Neurol. 2006, 199:130-142.
37. Liliensiek B., Weigand M.A., Bierhaus A., Nicklas W., Kasper M., Hofer S., et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 2004, 113:1641-1650.
38. Lue L.F., Yan S.D., Stern D.M., Walker D.G. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease. Curr. Drug Targets CNS Neurol. Disord. 2005, 4:249-266.
39. Ma L., Nicholson L.F. Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus. Brain Res. 2004, 1018:10-17.
40. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A.M., et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 2010, 16:413-419.
41. Maroso M., Balosso S., Ravizza T., Iori V., Wright C.I., French J., et al. Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 2011, 8:304-315.
42. Mazarati A., Maroso M., Iori V., Vezzani A., Carli M. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and receptor for advanced glycation end products. Exp. Neurol. 2011, 232:143-148.
43. Meneghini V., Francese M.T., Carraro L., Grilli M. A novel role for the receptor for advanced glycation end-products in neural progenitor cells derived from adult subventricular zone. Mol. Cell. Neurosci. 2010, 45:139-150.
44. Muller S., Bianchi M.E., Knapp S. Thermodynamics of HMGB1 interaction with duplex DNA. Biochemistry 2001, 40:10254-10261.
45. Oliveira A.C., de Alencar B.C., Tzelepis F., Klezewsky W., da Silva R.N., Neves F.S., et al. Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice. PLoS Pathog. 2010, 6:e1000870.
46. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007, 7:353-364.
47. Origlia N., Righi M., Capsoni S., Cattaneo A., Fang F., Stern D.M., et al. Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction. J. Neurosci. 2008, 28:3521-3530.
48. Parent J.M., Yu T.W., Leibowitz R.T., Geschwind D.H., Sloviter R.S., Lowenstein D.H. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J. Neurosci. 1997, 17:3727-3738.
49. Pernot F., Heinrich C., Barbier L., Peinnequin A., Carpentier P., Dhote F., et al. Inflammatory changes during epileptogenesis and spontaneous seizures in a mouse model of mesiotemporal lobe epilepsy. Epilepsia 2011, 52:2315-2325.
50. Pitkanen A., Lukasiuk K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol. 2011, 10:173-186.
51. Qiu J., Nishimura M., Wang Y., Sims J.R., Qiu S., Savitz S.I., et al. Early release of HMGB-1 from neurons after the onset of brain ischemia. J. Cereb. Blood Flow Metab. 2008, 28:927-938.
52. Ramakers C., Ruijter J.M., Deprez R.H., Moorman A.F. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 2003, 339:62-66.
53. Rao M.S., Shetty A.K. Efficacy of doublecortin as a marker to analyse the absolute number and dendritic growth of newly generated neurons in the adult dentate gyrus. Eur. J. Neurosci. 2004, 19:234-246.
54. Rauvala H., Rouhiainen A. Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors. Biochim. Biophys. Acta 2010, 1799:164-170.
55. Ravizza T., Lucas S.M., Balosso S., Bernardino L., Ku G., Noé F., et al. Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia 2006, 47:1160-1168.
56. Ravizza T., Gagliardi B., Noé F., Boer K., Aronica E., Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 2008, 29:142-160.
57. Riban V., Bouilleret V., Pham-Le B.T., Fritschy J.M., Marescaux C., Depaulis A. Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience 2002, 112:101-111.
58. Rolls A., Shechter R., London A., Ziv Y., Ronen A., Levy R., et al. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 2007, 9:1081-1088.
59. Sajithlal G., Huttunen H., Rauvala H., Munch G. Receptor for advanced glycation end products plays a more important role in cellular survival than in neurite outgrowth during retinoic acid-induced differentiation of neuroblastoma cells. J. Biol. Chem. 2002, 277:6888-6897.
60. Sakatani S., Seto-Ohshima A., Shinohara Y., Yamamoto Y., Yamamoto H., Itohara S., et al. Neural-activity-dependent release of S100B from astrocytes enhances kainate-induced gamma oscillations in vivo. J. Neurosci. 2008, 28:10928-10936.
61. Sakatani S., Yamada K., Homma C., Munesue S., Yamamoto Y., Yamamoto H., et al. Deletion of RAGE causes hyperactivity and increased sensitivity to auditory stimuli in mice. PLoS One 2009, 4:e8309.
62. Sara S.J. Retrieval and reconsolidation: toward a neurobiology of remembering. Learn. Mem. 2000, 7:73-84.
63. Sasaki N., Toki S., Chowei H., Saito T., Nakano N., Hayashi Y., et al. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res. 2001, 888:256-262.
64. Scharfman H.E. "Untangling" Alzheimer's disease and epilepsy. Epilepsy Curr. 2012, 12:178-183.
65. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 2000, 1498:99-111.
66. Serrano G.E., Lelutiu N., Rojas A., Cochi S., Shaw R., Makinson C.D., et al. Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus. J. Neurosci. 2011, 31:14850-14860.
67. Sha Y., Zmijewski J., Xu Z., Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J. Immunol. 2008, 180:2531-2537.
68. Shanmugam N., Kim Y.S., Lanting L., Natarajan R. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. J. Biol. Chem. 2003, 278:34834-34844.
69. Sims G.P., Rowe D.C., Rietdijk S.T., Herbst R., Coyle A.J. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 2010, 28:367-388.
70. Sloane J.A., Blitz D., Margolin Z., Vartanian T. A clear and present danger: endogenous ligands of Toll-like receptors. Neuromolecular Med. 2010, 12:149-163.
71. Stern D., Yan S.D., Yan S.F., Schmidt A.M. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv. Drug Deliv. Rev. 2002, 54:1615-1625.
72. Suzuki F., Heinrich C., Boehrer A., Mitsuya K., Kurokawa K., Matsuda M., et al. Glutamate receptor antagonists and benzodiazepine inhibit the progression of granule cell dispersion in a mouse model of mesial temporal lobe epilepsy. Epilepsia 2005, 46:193-202.
73. Tikellis C., Thomas M.C., Harcourt B.E., Coughlan M.T., Pete J., Bialkowski K., et al. Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E323-E330.
74. van Beijnum J.R., Buurman W.A., Griffioen A.W. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 2008, 11:91-99.
75. Vezzani A., Moneta D., Conti M., Richichi C., Ravizza T., De Luigi A., et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11534-11539.
76. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat. Rev. Neurol. 2011, 7:31-40.
77. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., et al. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 2003, 23:8692-8700.
78. Worrell G.A., Parish L., Cranstoun S.D., Jonas R., Baltuch G., Litt B. High-frequency oscillations and seizure generation in neocortical epilepsy. Brain 2004, 127:1496-1506.
79. Yang H., Wang H., Czura C.J., Tracey K.J. HMGB1 as a cytokine and therapeutic target. J. Endotoxin Res. 2002, 8:469-472.
80. Zattoni M., Mura M.L., Deprez F., Schwendener R.A., Engelhardt B., Frei K., et al. Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J. Neurosci. 2011, 31:4037-4050.
81. Zhang J., Takahashi H.K., Liu K., Wake H., Liu R., Maruo T., et al. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 2011, 42:1420-1428.
82. Zurolo E., Iyer A., Maroso M., Carbonell C., Anink J.J., Ravizza T., et al. Activation of TLR, RAGE and HMGB1 signaling in malformations of cortical development. Brain 2011, 134:1015-1032.